logo
Select company
Select metric
$ 1.71MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
33
Sector
60
Industry
71
History
79
$ 3.45Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information

Ticker

PYXS

Company Name

PYXIS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PYXIS ONCOLOGY INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PYXS - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 1.71M
3/31/2025$ 1.86M
12/31/2024$ 59.57M
9/30/2024$ 59.54M
6/30/2024$ 58.11M
3/31/2024$ 64.08M
12/31/2023$ 6.37M
9/30/2023$ 6.35M
6/30/2023$ 6.13M
3/31/2023$ 7K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) CF - Equity stands at $ 35K.
  • Over the past 5 years, PYXIS ONCOLOGY INC's average CF - Equity has been $ 48.11M.
  • The median CF - Equity for PYXIS ONCOLOGY INC during this period was $ 6.37M
  • PYXIS ONCOLOGY INC reached its highest CF - Equity over the past 5 years at $ 152.64M.
  • The lowest CF - Equity recorded by PYXIS ONCOLOGY INC in the same timeframe $ 7K

PYXIS ONCOLOGY INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
NTRB : NUTRIBAND INC $ 5.21MALGS : ALIGOS THERAPEUTICS INC $ 101.71MSTTK : SHATTUCK LABS INC $ -37KORMP : ORAMED PHARMACEUTICALS INC $ -2.85MCAMP : CAMP4 THERAPEUTICS CORP $ 76.46MARMP : ARMATA PHARMACEUTICALS INC $ 0DTIL : PRECISION BIOSCIENCES INC $ 25.68MNRXS : NEURAXIS INC $ 5MCBUS : CIBUS INC $ 0ABVC : ABVC BIOPHARMA INC $ 2.55M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

PYXS - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 7K

Minimum

Mar 31, 2023

$ 152.64M

Maximum

Jun 30, 2022

$ 48.11M

Average

$ 6.37M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M